Stock Yearly Return 2013
Start date: 12/31/2012
End date: 12/31/2013
Start price/share: $37.80
End price/share: $102.40
Dividends collected/share: $0.00
Total return: 170.90%
Average Annual Total Return: 170.90%
Starting investment: $10,000.00
Ending investment: $27,090.00
Years: 1.00


NVAX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare NVAX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into NVAX


Also see:
NVAX stock yearly return 2014
NVAX stock yearly return 2015
NVAX stock yearly return 2016
NVAX stock yearly return 2017
NVAX stock yearly return 2018
NVAX stock yearly return 2019
NVAX stock yearly return 2020
NVAX YTD return
NVAX average annual return 10 years
Novavax is a biotechnology company promoting improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, (NVX-CoV2373) and its nanoparticle seasonal quadrivalent influenza vaccine candidate (NanoFlu), are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. Co.'s technology may be used to target a variety of infectious diseases. Co.'s technology is paired with its proprietary immune stimulating adjuvants, developed at Novavax AB, its wholly owned Swedish subsidiary. The NVAX stock yearly return is shown above.

The yearly return on the NVAX stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2013 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the NVAX annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for NVAX:
NVAX SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Novavax (NVAX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

NVIV Average Annual Return
NVO Average Annual Return
NVRO Average Annual Return
NVTA Average Annual Return
NVTR Average Annual Return
NVUS Average Annual Return
NXTM Average Annual Return
NYMX Average Annual Return
OBLN Average Annual Return
OCUL Average Annual Return
More Healthcare companies »

 

NVAX Stock Yearly Return 2013 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.